CLINICAL_TRIALS
trial_result
· 2023-10-12
Clinical Trial Update: Dapagliflozin (DAPA) Effects in HFpEF [Phase 2]
Summary
Phase 2 trial investigating dapagliflozin effects in heart failure with preserved ejection fraction has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED | Results posted: 2023-10-12